Unveiling Stability: PROPENOL SR 40 - Propranolol Sustained-Release (40mg)

May 31, 2024

PROPENOL SR 40

Propranolol SR (40mg)

PROPENOL SR 40, featuring Propranolol Sustained-Release at a dosage of 40mg, emerges as a stalwart ally in the pursuit of stability and well-being. This article navigates through the intricacies of Propranolol SR, its mechanism of action, therapeutic applications, and the transformative benefits it offers in PROPENOL SR 40.

Understanding Propranolol SR (40mg): Propranolol Sustained-Release (SR) represents a modified-release formulation designed to provide prolonged therapeutic effects over an extended period. At a dosage of 40mg, Propranolol SR offers consistent plasma levels of the medication, ensuring sustained control of symptoms associated with hypertension, anxiety disorders, and migraines. By antagonizing beta-adrenergic receptors, Propranolol SR modulates sympathetic nervous system activity, leading to reductions in heart rate, blood pressure, and peripheral vascular resistance.

The Mechanism of Action: The mechanism of action of Propranolol SR mirrors that of its immediate-release counterpart, albeit with a prolonged duration of action. By blocking beta-adrenergic receptors, particularly β1 and β2 receptors, Propranolol SR attenuates sympathetic stimulation, resulting in decreased cardiac output, blood pressure, and myocardial oxygen demand. This sustained blockade of adrenergic activity underpins the therapeutic efficacy of PROPENOL SR 40 in managing hypertension and anxiety disorders.

Therapeutic Applications of PROPENOL SR 40: PROPENOL SR 40 serves as a versatile medication with a wide range of therapeutic applications. In the management of hypertension, Propranolol SR offers sustained reductions in blood pressure, promoting cardiovascular stability and reducing the risk of cardiovascular events. Additionally, Propranolol SR finds utility in anxiety disorders, providing prolonged relief from symptoms such as palpitations, tremors, and sweating. Furthermore, PROPENOL SR 40 demonstrates efficacy in migraine prophylaxis, offering sustained control of migraine frequency and severity.

Clinical Efficacy and Safety Profile: Clinical studies and real-world evidence support the efficacy and safety of PROPENOL SR 40 in managing hypertension, anxiety disorders, and migraines. The sustained-release formulation maintains stable plasma levels of Propranolol, minimizing fluctuations in therapeutic effect and reducing the frequency of dosing. Common side effects such as fatigue, dizziness, and gastrointestinal disturbances may occur but are generally mild and transient. However, healthcare providers should exercise caution when prescribing Propranolol SR to patients with preexisting cardiac conditions, respiratory disorders, or hypotension.

Optimal Dosage and Administration: The optimal dosage of PROPENOL SR 40 may vary based on individual patient factors, the severity of symptoms, and treatment response. Initiation with a low dose and titration based on clinical response and tolerability is recommended to optimize therapeutic benefits while minimizing the risk of adverse effects. Adherence to prescribed dosing schedules is essential to maintain stable plasma levels of Propranolol SR and ensure consistent efficacy in managing hypertension, anxiety disorders, and migraines.

Conclusion: PROPENOL SR 40, featuring Propranolol Sustained-Release at a dosage of 40mg, emerges as a reliable therapeutic option in the management of hypertension, anxiety disorders, and migraines. By offering sustained control of symptoms and minimizing the need for frequent dosing, PROPENOL SR 40 promotes stability and well-being for individuals grappling with these chronic conditions. Healthcare providers can leverage the therapeutic benefits of PROPENOL SR 40 to tailor treatment regimens that address the unique needs of each patient, fostering cardiovascular health and mental resilience. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW

SHARE WITH